| Name | [(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)-4-methyloxolan-3-yl] (2S)-2-amino-3-methylbutanoate |
|---|---|
| Synonyms |
Valopicitabine [INN]
NMC-283 NM-283 val-mCyd Valopicitabine UNII-I2T0B5G94M |
| Description | Valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine, acts as a promising antiviral agent for reasearch of chronic HCV infection[1]. |
|---|---|
| Related Catalog | |
| Target |
HCV[1] |
| In Vivo | Valopicitabine (NM 283) has potent antiviral activity against chronic hepatitis C virus genotype-1 in the chimpanzee[1]. Valopicitabine exhibits moderate Cmax (3.62 ug/mL) and terminal elimination half-lives (T1/2 0.64 h) following oral administration (100 mg/kg) in Sprague-Dawley rats[2]. |
| References |
| Molecular Formula | C15H24N4O6 |
|---|---|
| Molecular Weight | 356.37400 |
| Exact Mass | 356.17000 |
| PSA | 162.92000 |